|
Sygnis Sygnis develops biotech tools based on polymerases, with potential applications in several fields such as personalized medicine. Personalized medicine aims to design specific treatments for each patient according to their genetic characteristics. Sygnis includes in its portfolio a potential blockbuster QualiPhi®, that has the potential to become a major breakthrough technology in the development of personalized medicine. |
 |